X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE LUPIN LTD SUVEN LIFE/
LUPIN LTD
 
P/E (TTM) x 14.0 134.2 10.5% View Chart
P/BV x 3.3 2.5 133.6% View Chart
Dividend Yield % 0.5 1.0 52.3%  

Financials

 SUVEN LIFE   LUPIN LTD
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
LUPIN LTD
Mar-17
SUVEN LIFE/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs2291,750 13.1%   
Low Rs1511,384 10.9%   
Sales per share (Unadj.) Rs42.7387.4 11.0%  
Earnings per share (Unadj.) Rs6.956.6 12.1%  
Cash flow per share (Unadj.) Rs8.576.8 11.1%  
Dividends per share (Unadj.) Rs1.007.50 13.3%  
Dividend yield (eoy) %0.50.5 110.1%  
Book value per share (Unadj.) Rs52.4298.9 17.5%  
Shares outstanding (eoy) m127.28451.58 28.2%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x4.44.0 109.9%   
Avg P/E ratio x27.727.7 100.2%  
P/CF ratio (eoy) x22.220.4 109.1%  
Price / Book Value ratio x3.65.2 69.1%  
Dividend payout %14.613.2 110.2%   
Avg Mkt Cap Rs m24,158707,513 3.4%   
No. of employees `0001.016.8 6.1%   
Total wages/salary Rs m52228,495 1.8%   
Avg. sales/employee Rs Th5,349.710,418.3 51.3%   
Avg. wages/employee Rs Th513.51,697.0 30.3%   
Avg. net profit/employee Rs Th858.11,523.0 56.3%   
INCOME DATA
Net Sales Rs m5,435174,943 3.1%  
Other income Rs m2111,065 19.8%   
Total revenues Rs m5,646176,008 3.2%   
Gross profit Rs m1,29144,931 2.9%  
Depreciation Rs m2149,122 2.3%   
Interest Rs m571,525 3.7%   
Profit before tax Rs m1,23135,349 3.5%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3599,785 3.7%   
Profit after tax Rs m87225,575 3.4%  
Gross profit margin %23.725.7 92.5%  
Effective tax rate %29.227.7 105.3%   
Net profit margin %16.014.6 109.7%  
BALANCE SHEET DATA
Current assets Rs m4,917119,542 4.1%   
Current liabilities Rs m1,18661,206 1.9%   
Net working cap to sales %68.633.3 205.9%  
Current ratio x4.12.0 212.3%  
Inventory Days Days6276 81.8%  
Debtors Days Days3190 34.2%  
Net fixed assets Rs m3,154131,660 2.4%   
Share capital Rs m127903 14.1%   
"Free" reserves Rs m6,543134,073 4.9%   
Net worth Rs m6,670134,976 4.9%   
Long term debt Rs m25956,478 0.5%   
Total assets Rs m8,157266,073 3.1%  
Interest coverage x22.724.2 93.8%   
Debt to equity ratio x00.4 9.3%  
Sales to assets ratio x0.70.7 101.3%   
Return on assets %11.410.2 111.8%  
Return on equity %13.118.9 69.0%  
Return on capital %18.619.3 96.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,99681,885 6.1%   
Fx outflow Rs m95921,506 4.5%   
Net fx Rs m4,03760,378 6.7%   
CASH FLOW
From Operations Rs m1,08841,148 2.6%  
From Investments Rs m-3,107-25,287 12.3%  
From Financial Activity Rs m-3004,332 -6.9%  
Net Cashflow Rs m-2,31920,193 -11.5%  

Share Holding

Indian Promoters % 63.4 46.6 136.1%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 0.0 31.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 10.1 361.4%  
Shareholders   37,287 98,259 37.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   PLETHICO PHARMA  BIOCON LTD  J.B.CHEMICALS  ALKEM LABORATORIES  AJANTA PHARMA  

Compare SUVEN LIFE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


May 25, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS